Abstract:Human papillomaviruses (HPVs) contribute to approximately 5% of all human cancers. Species-specific barriers limit the ability to study HPV pathogenesis in animal models. Murine papillomavirus (MmuPV1) provides a powerful tool to study the roles of papillomavirus genes in pathogenesis arising from a natural infection. We previously identified Protein Tyrosine Phosphatase Non-Receptor Type 14 (PTPN14), a tumor suppressor targeted by HPV E7 proteins, as a putative cellular target of MmuPV1 E7. Here, we confirmed the MmuPV1 E7-PTPN14 interaction. Based on the published structure of the HPV18 E7/PTPN14 complex, we generated a MmuPV1 E7 mutant, E7 K81S , that was defective for binding PTPN14. Wild-type (WT) and E7 K81S mutant viral genomes replicated as extrachromosomal circular DNAs to comparable levels in mouse keratinocytes. E7 K81S mutant virus (E7 K81S MmuPV1) was generated and used to infect FoxN/Nude mice. E7 K81S MmuPV1 caused neoplastic lesions at a frequency similar to that of WT MmuPV1, but the lesions arose later and were smaller than WT-induced lesions. The E7 K81S MmuPV1-induced lesions also had a trend towards a less severe grade of neoplastic disease. In the lesions, E7 K81S MmuPV1 supported the late (productive) stage of the viral life cycle and promoted E2F activity and cellular DNA synthesis in suprabasal epithelial cells to similar degrees as WT MmuPV1. There was a similar frequency of lateral spread of infections among mice infected with E7 K81S or WT MmuPV1. Compared to WT MmuPV1-induced lesions, E7 K81S MmuPV1-induced lesions had a significant expansion of cells expressing differentiation markers, Keratin 10 and Involucrin. We conclude that an intact PTPN14 binding site is necessary for MmuPV1 E7's ability to contribute to papillomavirus-induced pathogenesis and this correlates with MmuPV1 E7 causing a delay in epithelial differentiation, which is a hallmark of papillomavirus-induced neoplasia. Human papillomaviruses cause human cancers largely through virally encoded E6 and E7 oncogenes. A murine papillomavirus, MmuPV1, causes lesions in laboratory mice that mimic features of human papillomavirus-induced lesions including cancer. In this study, we investigated how the interaction of MmuPV1 E7 with the cellular tumor suppressor protein, PTPN14, contributes to viral pathogenesis using a MmuPV1 E7 mutant defective for interacting with PTPN14, E7 K81S . We examined phenotypic differences between the E7 K81S and wild type MmuPV1 in tissue culture and in mice. The E7 K81S mutant genome was able to replicate as a nuclear plasmid in tissue culture. In vivo, E7 K81S mutant virus caused dysplastic lesions like wild type virus; however, they were smaller in size, arose later, and trended towards being less severe in their grade of neoplastic disease. The E7 K81S -induced lesions showed evidence for increased E2F activation and reprogramming of suprabasal cells to support DNA synthesis similar to that seen in lesions induced by wild type virus. One clear molecular difference was that the E7 K81S -induced lesions showed an expansion of cells expressing differentiation markers. Our study shows that an intact PTPN14 binding site is important for MmuPV1 E7's ability to contribute to MmuPV1-induced skin disease.

Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment

Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection

Digital RNA Sequencing of Human Epidermal Keratinocytes Carrying Human Papillomavirus Type 16 E7

Human papillomavirus infection and host innate immune responses

Autophagy is Induced in Human Keratinocytes During Human Papillomavirus 11 Pseudovirion Entry

Induction of Co-Inhibitory Molecule CTLA-4 by Human Papillomavirus E7 Protein Through Downregulation of Histone Methyltransferase JHDM1B Expression

Key aspects of papillomavirus infection influence the host cervicovaginal microbiome in a preclinical murine papillomavirus (MmuPV1) infection model

MmuPV1 E7's interaction with PTPN14 delays Epithelial differentiation and contributes to virus-induced skin disease

Hpv E7 Inhibits Cell Pyroptosis By Promoting Trim21-Mediated Degradation And Ubiquitination Of The Ifi16 Inflammasome

Immune Status, Strain Background, and Anatomic Site of Inoculation Affect Mouse Papillomavirus (MmuPV1) Induction of Exophytic Papillomas or Endophytic Trichoblastomas

Monitoring mouse papillomavirus-associated cancer development using longitudinal Pap smear screening

Cytokeratin-17 expression is commonly observed in keratinocytic skin tumours and controls tissue homeostasis impacting HPV protein expression

Micrornas Are Biomarkers of Oncogenic Human Papillomavirus Infections

PRMT1 Modulates Alternative Splicing to Enhance HPV18 mRNA Stability and Promote the Establishment of Infection

Advances of Cytokeratin Promoters in HPV Transgenic Mice

Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1

Advances in research on mouse models of papillomavirus infection

A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis

Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance

Invasive cancer and spontaneous regression two weeks after papillomavirus infection

A Critical Role for p53 during the HPV16 Life Cycle